Close Menu

NEW YORK (GenomeWeb) – Sema4 and California Cryobank today announced a collaboration to bring extensive genetic screening to new Cryobank sperm donors via its DNA Advantage Program using Sema4's Expanded Carrier Screen.

Through the DNA Advantage Program, Cryobank will have access to Sema4's extensive capabilities in reproductive health testing, including DNA extraction and storage for a number of sample types and karyotyping.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

AstraZeneca has released its coronavirus vaccine trial protocol, according to the New York Times.

Time magazine looks into how liquid biopsies are changing cancer care.

According to the Guardian, more than 150 countries have signed on to a global SARS-CoV-2 vaccine plan.

In PNAS this week: similar muscle protein patterns across hypertrophic cardiomyopathy phenotypes, analysis of gene expression and brain anatomy in major depression, and more.